My PhD investigates how bacterial biofilms respond to biocidal challenge, and explores mechanisms of biocide-antibiotic cross-resistance in archetypal biofilm-forming pathogens. I am working closely with Procter & Gamble to develop an in vitro model predictive of biofilm behaviour for assessing efficacy and selective pressures of biocides.
I graduated from the University of Manchester in 2017 with a Master of Science degree in Medical Microbiology with Distinction. My thesis investigated mechanisms of fosfomycin heteroresistance among a cohort of multidrug-resistant Enterobacteriaceae causative of upper urinary tract infections. At undergraduate, I read Biology at the University of Chester and graduated with First Class Honours in 2016. My dissertation focused on validating a plate-based biocide sterilisation model and investigating variations in intrinsic susceptibility to benzalkonium chloride. It was graded highest in the department and subsequently published in Bioscience Horizons: The International Journal of Student Research.
From 2015 to 2017 I was employed by ALS Environmental alongside my studies. I worked in the method development laboratory performing gas chromatography-mass spectrometry analysis of biocides and plasticisers in wastewater effluent for the Chemical Investigation Programme 2, as part of the EU Water Framework Directive. Later, I became responsible for overseeing a microbiology laboratory involved in development of UKAS ISO 17025-accredited methods for monitoring pathogens and faecal indicator organisms in water treatment processes.